Covered recipient · General Payments record
ROBERT W CARY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$11,498.50
- Reported across 793 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.92 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $97.46 | 2 |
| Astellas Pharma US Inc | $35.14 | 2 |
| Novo Nordisk AS | $33.32 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.01 | 2 |
| Lilly USA, LLC | $17.93 | 1 |
| Amgen Inc. | $14.69 | 1 |
| Acerta Pharma LLC | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.69 | 01/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117521825 | CMS |
| Astellas Pharma US Inc | $18.12 | 01/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1139294368 | CMS |
| Astellas Pharma US Inc | $17.02 | 02/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1139292018 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.37 | 02/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1104606698 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.20 | 01/03/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1118115859 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.81 | 02/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1118115857 | CMS |
| Lilly USA, LLC | $17.93 | 02/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135371322 | CMS |
| Novo Nordisk Inc | $18.34 | 01/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1096964843 | CMS |
| Novo Nordisk Inc | $14.98 | 02/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1097445748 | CMS |
| PFIZER INC. | $15.61 | 01/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131531476 | CMS |
| PFIZER INC. | $81.85 | 02/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131542496 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.